RSU1 and central nervous system cancer: The least aggressive glioma cells (H4 and SW1088) exhibited increased motility following RSU-1 silencing in contrast to the most aggressive glioma cells (A172 and U87-MG), which exhibited decreased motility after RSU-1 silencing (Fig. 5A,B).